FIELD: chemistry.
SUBSTANCE: present invention relates to immunology and biotechnology. Disclosed are: versions of an isolated molecule of a human IL-6 antibody, which contain VH and VL; nucleic acid which includes an antibody-coding nucleotide sequence; a cell for obtaining the antibody molecule which is transformed by said nucleic acid. Described is a method of obtaining the antibody by cell culturing, a composition and a method of obtaining a composition of the antibody molecule.
EFFECT: invention can be used in medicine for treating diseases associated with IL-6.
34 cl, 1 dwg, 11 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-IL-1R1 BINDING MEMBERS | 2009 |
|
RU2555532C2 |
| HUMAN IL-13 ANTIBODY MOLECULES | 2004 |
|
RU2387667C2 |
| NEUTRALIZING BINDING MOLECULES DIRECTED AGAINST INFLUENZA VIRUS, AND METHODS OF THEIR APPLICATION | 2016 |
|
RU2721706C2 |
| ELEMENT BOUND WITH INTERLEUKIN-4 RECEPTOR α (IL-4Rα)-173 | 2008 |
|
RU2490278C2 |
| ISOLATED ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT SPECIFIC FOR HUMAN IMMUNOGLOBULIN E (VERSIONS), NUCLEIC ACID MOLECULE CODING IT, HOST CELL, METHOD FOR PREPARING ANTIBODY OR ITS ANTIGEN-BINDONG FRAGMENT, PHARMACEUTICAL COMPOSITION, USE THEREOF FOR TREATING IgE-ASSOCIATED DISEASES | 2008 |
|
RU2466140C2 |
| ANTIGENS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE | 2012 |
|
RU2612878C2 |
| ANTIBODY AGAINST IL-4R AND APPLICATION THEREOF | 2018 |
|
RU2758091C1 |
| PARTNERS OF SPECIFIC BINDING WITH NGF | 2006 |
|
RU2406728C2 |
| RECOVERED HUMAN ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT (VERSIONS), METHOD OF TREATING hTNFα-MEDIATED DISEASES WITH MEDIATION THEREOF (VERSIONS), PHARMACEUTICAL COMPOSITION, RECOMBINANT HUMAN ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT, RECOVERED NUCLEIC ACID (VERSIONS) | 2005 |
|
RU2458704C9 |
| ANTIBODY TO AMYLOID BETA | 2013 |
|
RU2651486C2 |
